Home

JEFFREY R JAY

CIK 1239607 · last filed 2017-06-21

JEFFREY R JAY is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $19.5M of ADMS on Jun 21, 2017. Across all open-market trades the lifetime net is −$27.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $66.3M across reported positions. 56 SEC filings were submitted jointly with GREAT POINT PARTNERS LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$66.26M

Companies

3

Total Filings

6

Lifetime Open-Market Net

-$27.08M

Filer Profile

Reported Address
GREAT POINT PARTNERS, LLC
165 MASON STREET, 3RD FLOOR
GREENWICH, CT 06830
Related Filers
GREAT POINT PARTNERS LLC — 56 joint filings, latest 2018-09-14
DAVID KROIN — 18 joint filings, latest 2018-09-14
GREAT POINT PARTNERS I LP — 4 joint filings, latest 2015-07-16
Great Point Partners I GP, LLC — 4 joint filings, latest 2015-07-16
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Adamas Pharmaceuticals Inc (ADMS) Delisted 10%+ Owner 2,231,351 $8.22 $18.34M -$19.47M 1 2017-06-21
MEMY 10%+ Owner 4,079,270 $16.24 $66.26M -$3.36M 3 2008-12-11
MEDecision, Inc. (MEDE) Delisted 10%+ Owner 996,574 — — -$4.25M 1 2008-07-09

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-06-21 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −1,140,000 -$19.47M EDGAR
2009-01-08 — U −26,477,280 -$16.15M
2008-12-11 MEMY Sell (S) −2,931,675 -$1.73M EDGAR
2008-07-09 MEDecision, Inc. (MEDE) Delisted Mixed −646,296 -$4.25M EDGAR
2007-10-22 MEMY Sell (S) −1,718,000 -$1.63M EDGAR
2007-01-23 MEMY Exer (X) +4,986,478 $5.53M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.